14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.11 $8.20 Friday, 3rd May 2024 GLUE stock ended at $5.65. This is 0.89% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.63% from a day low at $5.65 to a day high of $5.85.
90 days $4.19 $8.84
52 weeks $2.44 $8.84

Historical Monte Rosa Therapeutics, Inc. prices

Date Open High Low Close Volume
Sep 28, 2023 $5.58 $5.58 $4.73 $4.78 262 451
Sep 27, 2023 $6.47 $6.49 $5.60 $5.62 135 877
Sep 26, 2023 $6.06 $6.83 $6.06 $6.39 157 107
Sep 25, 2023 $6.00 $6.31 $5.92 $6.07 147 628
Sep 22, 2023 $6.14 $6.14 $5.95 $6.00 69 898
Sep 21, 2023 $5.93 $6.20 $5.86 $6.14 133 339
Sep 20, 2023 $6.07 $6.13 $5.98 $5.98 131 408
Sep 19, 2023 $6.02 $6.10 $5.82 $6.04 179 082
Sep 18, 2023 $5.99 $6.03 $5.89 $6.02 136 353
Sep 15, 2023 $6.03 $6.26 $5.96 $6.01 454 329
Sep 14, 2023 $6.00 $6.05 $5.87 $6.03 174 313
Sep 13, 2023 $5.95 $6.00 $5.85 $5.98 145 653
Sep 12, 2023 $6.05 $6.05 $5.92 $5.95 118 398
Sep 11, 2023 $6.00 $6.10 $5.94 $6.04 113 490
Sep 08, 2023 $6.00 $6.09 $5.92 $5.97 101 040
Sep 07, 2023 $6.00 $6.10 $5.96 $6.00 118 979
Sep 06, 2023 $6.16 $6.18 $5.76 $6.04 288 710
Sep 05, 2023 $6.22 $6.30 $5.96 $6.16 213 589
Sep 01, 2023 $5.92 $6.27 $5.92 $6.20 101 508
Aug 31, 2023 $6.28 $6.33 $5.85 $5.87 306 753
Aug 30, 2023 $6.31 $6.41 $6.22 $6.28 61 403
Aug 29, 2023 $6.04 $6.32 $6.01 $6.30 124 475
Aug 28, 2023 $6.03 $6.21 $6.00 $6.08 99 351
Aug 25, 2023 $6.42 $6.45 $5.98 $6.01 132 764
Aug 24, 2023 $6.39 $6.45 $6.34 $6.41 75 305
Click to get the best stock tips daily for free!

About Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics. Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, ... GLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT